M. D. Wit

Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow

N. Kröger, S. Bielack, A. Zander, 1999, Bone Marrow Transplantation.

Six, Not Eight Cycles of Bi-Weekly CHOP with Rituximab (R-CHOP-14) Is the Preferred Treatment for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

N. Schmitz, M. Pfreundschuh, M. Loeffler, 2005 .

Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapy

N. Kröger, A. Zander, W. Krüger, 1998, Bone Marrow Transplantation.

Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia

N. Kröger, S. Hegewisch-Becker, S. Bielack, 1998, Bone Marrow Transplantation.

European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG).

W. Siegert, S. Fosså, S. Culine, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[18F]-FDG-PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial.

H. Amthauer, W. Brenner, H. Schirrmeister, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma.

R. Buchert, D. Bumann, K. Bohuslavizki, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma.

D. Bumann, M. Clausen, W. Beyer, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

T. Brümmendorf, K. Spiekermann, M. Pfreundschuh, 2017, Leukemia.

Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II

H. Eich, T. Lenarz, V. Budach, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.